Inverse Association between Serum 25-hydroxyvitamin D Levels and Risk of Suspected Non-Alcoholic Fatty Liver Disease in Obese Population

Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders

(2019) William S. Blaner   PHARMACOLOGY & THERAPEUTICS

Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D

(2019) Alan Sacerdote et al.   Current Diabetes Reports

Vitamin D: Classic and Novel Actions

(2018) Ángel Gil et al.   ANNALS OF NUTRITION AND METABOLISM

Vitamin D status in South Korean population

(2018) Ju-Hyun Park et al.   MEDICINE

Mechanisms of NAFLD development and therapeutic strategies

(2018) Scott L. Friedman et al.   NATURE MEDICINE

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

(2018) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease

(2018) JoAnn E. Manson et al.   NEW ENGLAND JOURNAL OF MEDICINE

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

New trends on obesity and NAFLD in Asia

(2017) Jian-Gao Fan et al.   JOURNAL OF HEPATOLOGY

Vitamin D and type 2 diabetes

(2017) Paul Lips et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention

(2017) Michael F. Holick   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future

(2017) et al.   Nutrients

Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease

(2016) Yoosoo Chang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis

(2016) Andrea Marengo et al.   Annual Review of Medicine

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

(2016) Ilaria Barchetta et al.   BMC Medicine

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

The Hepatic Expression of Vitamin D Receptor Is Inversely Associated With the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients

(2015) Salvatore Petta et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Vitamin D: A new player in non-alcoholic fatty liver disease?

(2015) Myrto Eliades   WORLD JOURNAL OF GASTROENTEROLOGY

High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome

(2013) Eun-Jung Rhee et al.   ENDOCRINE JOURNAL

Vitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association?

(2013) Ryan M. Kwok et al.   HEPATOLOGY

The burden of liver disease in Europe: A review of available epidemiological data

(2013) Martin Blachier et al.   JOURNAL OF HEPATOLOGY

NAFLD in Asia—as common and important as in the West

(2013) Geoffrey C. Farrell et al.   Nature Reviews Gastroenterology & Hepatology

Vitamin D signalling in adipose tissue

(2012) Cherlyn Ding et al.   BRITISH JOURNAL OF NUTRITION

Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus

(2012) Ilaria Barchetta et al.   HEPATOLOGY

Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss

(2012) L Wamberg et al.   INTERNATIONAL JOURNAL OF OBESITY

Low Serum 25-Hydroxyvitamin D Is Associated with Increased Risk of the Development of the Metabolic Syndrome at Five Years: Results from a National, Population-Based Prospective Study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab)

(2012) Claudia Gagnon et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes

(2011) Ilaria Barchetta et al.   BMC Medicine

Serum Vitamin D Concentrations and Unexplained Elevation in ALT Among US Adults

(2011) Suthat Liangpunsakul et al.   DIGESTIVE DISEASES AND SCIENCES

Endpoints and clinical trial design for nonalcoholic steatohepatitis

(2011) Arun J. Sanyal et al.   HEPATOLOGY

Vitamin D deficiency and HCV chronic infection: What comes first?

(2011) Davide Bitetto et al.   JOURNAL OF HEPATOLOGY

Polychlorinated Biphenyls, Lead, and Mercury Are Associated with Liver Disease in American Adults: NHANES 2003–2004

(2010) Matt Cave et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy

(2010) Christian Markus Lange et al.   JOURNAL OF HEPATOLOGY

Vitamin D Deficiency in Adults: When to Test and How to Treat

(2010) Kurt A. Kennel et al.   MAYO CLINIC PROCEEDINGS

Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004

(2009) Adit A. Ginde et al.   ARCHIVES OF INTERNAL MEDICINE

Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

(2009) Jeong-Hoon Lee et al.   DIGESTIVE AND LIVER DISEASE

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

(2009) Amalia Gastaldelli et al.   HEPATOLOGY

Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population

(2008) Constance E. Ruhl et al.   GASTROENTEROLOGY

Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

(2007) Rami Moucari et al.   GASTROENTEROLOGY